Article
[Congenital myasthenic syndromes due to mutations in the rapsyn gene].
Revue neurologique - 1 May 2004
Eymard B, Ioos C, Barois A, Estournet B, Mayer M, Fournier E, Yasaki E, Prioleau C, Bauché S, Gaudon K, Leroy J P, Koenig J, Richard P, Hantaï D
Abstract excerpt
Congenital myasthenic syndromes (CMS) are genetic diseases characterized by dysfunctional neuromuscular transmission and usually start during the neonatal period. Most are due to postsynaptic abnormalities, specifically to mutations in the acetylcholine receptor (AChR) genes. In 2002, the group of A Engel reported the first cases of CMS with mutations in the gene coding rapsyn, a postsynaptic molecule which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
